Description: Vivani Medical, Inc. develops and commercializes drug and device implants to treat patients with chronic diseases with unmet medical need. Its lead product candidate is NPM-119, a GLP-1 receptor agonist under development to treat patients with Type 2 diabetes. The company is based in Sylmar, California.
Home Page: www.vivani.com
VANI Technical Analysis
5858 Horton Street
EmeryVille,
CA
94608
United States
Phone:
818 833 5000
Officers
Name | Title |
---|---|
Mr. Adam Mendelsohn Ph.D. | Co-Founder, Chairman & CEO |
Mr. Truc Le M.B.A. | Chief Operations Officer |
Dr. Lisa E. Porter M.D. | Chief Medical Officer |
Mr. Donald Dwyer M.B.A. | Chief Bus. Officer |
Dr. Kayte Fischer Ph.D. | Co-Founder |
Ms. Brigid Ann Makes | Chief Financial Officer |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
Forward PE: | 0 |
---|---|
Trailing PE: | 0 |
Price-to-Book MRQ: | 1.5904 |
Price-to-Sales TTM: | 0 |
IPO Date: | 2014-11-19 |
Fiscal Year End: | December |
Full Time Employees: | 0 |